S Miriam Lenhard

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. ncbi Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer
    Miriam Lenhard
    Department of Obstetrics and Gynecology, Grosshadern Campus, Ludwig Maximilians University Hospital, Munich, Germany
    BMC Cancer 12:2. 2012
  2. ncbi Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors
    Miriam S Lenhard
    Department of Obstetrics and Gynecology, Ludwig Maximilians University Munich, Campus Grosshadern, Munich, Germany
    Clin Chem Lab Med 47:537-42. 2009
  3. ncbi Three-dimensional pelvimetry by computed tomography
    M Lenhard
    Department of Obstetrics and Gynecology, Ludwig Maximilians University Munich, Campus Grosshadern, Munich, Germany
    Radiol Med 114:827-34. 2009
  4. ncbi Relapse and survival in early-stage ovarian cancer
    S Miriam Lenhard
    Department of Obstetrics and Gynecology, Ludwig Maximilians University Munich, Campus Grosshadern, Marchioninistrasse 15, Munich 80337, Germany
    Arch Gynecol Obstet 280:71-7. 2009
  5. ncbi PET-CT in recurrent ovarian cancer: impact on treatment planning
    Miriam S Lenhard
    Department of Obstetrics and Gynecology, Ludwig Maximilians University Munich, Campus Grosshadem, Munich, Germany
    Anticancer Res 28:2303-8. 2008
  6. ncbi Predictive value of PET-CT imaging versus AGO-scoring in patients planned for cytoreductive surgery in recurrent ovarian cancer
    S M Lenhard
    Department of Obstetrics and Gynecology, Ludwig Maximilians University Munich, Campus Grosshadern, Marchioninistrasse 15, 80337 Munich, Germany
    Eur J Obstet Gynecol Reprod Biol 140:263-8. 2008
  7. ncbi Breast cancer and pregnancy: challenges of chemotherapy
    Miriam S Lenhard
    Department of Obstetrics and Gynecology, Campus Grosshadern, Ludwig Maximilians University of Munich, Marchioninistrasse 15, 80337 Munich, Germany
    Crit Rev Oncol Hematol 67:196-203. 2008
  8. ncbi Phyllodes tumour of the breast: clinical follow-up of 33 cases of this rare disease
    Miriam S Lenhard
    Department of Obstetrics and Gynecology, University Hospital Munich, Ludwig Maximilians University of Munich, Grosshadern, Marchioninistrasse 15, Munich, Germany
    Eur J Obstet Gynecol Reprod Biol 138:217-21. 2008
  9. ncbi Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours
    Miriam Lenhard
    Department of Obstetrics and Gynaecology, Campus Grosshadern, Ludwig Maximilians University, Munich, Germany
    Clin Chem Lab Med 45:657-61. 2007
  10. ncbi Obstetrical and gynecological writing and publishing in Europe
    Miriam S Lenhard
    Department of Obstetrics and Gynecology, Ludwig Maximilians University Munich, Campus Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany
    Eur J Obstet Gynecol Reprod Biol 129:119-23. 2006

Collaborators

Detail Information

Publications18

  1. ncbi Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer
    Miriam Lenhard
    Department of Obstetrics and Gynecology, Grosshadern Campus, Ludwig Maximilians University Hospital, Munich, Germany
    BMC Cancer 12:2. 2012
    ....
  2. ncbi Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors
    Miriam S Lenhard
    Department of Obstetrics and Gynecology, Ludwig Maximilians University Munich, Campus Grosshadern, Munich, Germany
    Clin Chem Lab Med 47:537-42. 2009
    ..The aim of this study was to assess the prognostic value of cancer antigen (CA) 125 and CA 72-4 in patients with ovarian borderline tumor (BOT)...
  3. ncbi Three-dimensional pelvimetry by computed tomography
    M Lenhard
    Department of Obstetrics and Gynecology, Ludwig Maximilians University Munich, Campus Grosshadern, Munich, Germany
    Radiol Med 114:827-34. 2009
    ..This study was undertaken to assess the agreement of computed tomography (CT) pelvimetry with different postprocessing techniques...
  4. ncbi Relapse and survival in early-stage ovarian cancer
    S Miriam Lenhard
    Department of Obstetrics and Gynecology, Ludwig Maximilians University Munich, Campus Grosshadern, Marchioninistrasse 15, Munich 80337, Germany
    Arch Gynecol Obstet 280:71-7. 2009
    ..To analyze the prognostic influence of patient characteristics, diagnostic markers or therapeutic procedures in women diagnosed with early ovarian cancer based on relapse and survival in long term follow-up...
  5. ncbi PET-CT in recurrent ovarian cancer: impact on treatment planning
    Miriam S Lenhard
    Department of Obstetrics and Gynecology, Ludwig Maximilians University Munich, Campus Grosshadem, Munich, Germany
    Anticancer Res 28:2303-8. 2008
    ..Positron emission tomography-computed tomography (PET-CT) is currently not established in the management of recurrent ovarian cancer. Here, its value in diagnosis and therapy planning was evaluated...
  6. ncbi Predictive value of PET-CT imaging versus AGO-scoring in patients planned for cytoreductive surgery in recurrent ovarian cancer
    S M Lenhard
    Department of Obstetrics and Gynecology, Ludwig Maximilians University Munich, Campus Grosshadern, Marchioninistrasse 15, 80337 Munich, Germany
    Eur J Obstet Gynecol Reprod Biol 140:263-8. 2008
    ..To assess the predictive value of positron emission tomography computed tomography (PET-CT) imaging in comparison to AGO-scoring in patients planned for cytoreductive surgery in recurrent ovarian cancer...
  7. ncbi Breast cancer and pregnancy: challenges of chemotherapy
    Miriam S Lenhard
    Department of Obstetrics and Gynecology, Campus Grosshadern, Ludwig Maximilians University of Munich, Marchioninistrasse 15, 80337 Munich, Germany
    Crit Rev Oncol Hematol 67:196-203. 2008
    ..As evidence-based data on diagnostics and treatment is lacking, current recommendations mostly derive from nonrandomized experiences. We reviewed the current literature with focus on chemotherapy during pregnancy and lactation...
  8. ncbi Phyllodes tumour of the breast: clinical follow-up of 33 cases of this rare disease
    Miriam S Lenhard
    Department of Obstetrics and Gynecology, University Hospital Munich, Ludwig Maximilians University of Munich, Grosshadern, Marchioninistrasse 15, Munich, Germany
    Eur J Obstet Gynecol Reprod Biol 138:217-21. 2008
    ..The "cystosarcoma phyllodes" of the breast is a rare entity which accounts for 0.5% of all breast neoplasms. The aim of our study was to analyse the clinical management with respect to patient outcome...
  9. ncbi Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours
    Miriam Lenhard
    Department of Obstetrics and Gynaecology, Campus Grosshadern, Ludwig Maximilians University, Munich, Germany
    Clin Chem Lab Med 45:657-61. 2007
    ..Sertoli-Leydig cell tumours of the ovary account for only 0.2% of malignant ovarian tumours. Two-thirds of all patients become apparent due to the tumour's hormone production...
  10. ncbi Obstetrical and gynecological writing and publishing in Europe
    Miriam S Lenhard
    Department of Obstetrics and Gynecology, Ludwig Maximilians University Munich, Campus Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany
    Eur J Obstet Gynecol Reprod Biol 129:119-23. 2006
    ..To assess the number and quality of scientific articles published by authors from the European Union (EU) and Germany in the field of obstetrics and gynecology...
  11. ncbi The high-grade endometrial sarcoma: a rare entity
    S M Lenhard
    Department of Obstetrics and Gynecology, Ludwig Maximilians University Munich, Campus Grosshadern, Marchioninistrasse 15, 80337, Munich, Germany
    Arch Gynecol Obstet 274:56-9. 2006
    ..It is subclassified into a high-grade and a prognostically better low-grade type. Evidence-based data for a standardized therapy is lacking...
  12. ncbi Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort
    Miriam S Lenhard
    Department of Obstetrics and Gynecology, Ludwig Maximilians University Munich, Campus Grosshadern, Munich, Germany
    Eur J Obstet Gynecol Reprod Biol 145:189-94. 2009
    ..To assess long-term survival and relapse rate of patients diagnosed with a borderline tumor of the ovary (BOT) with special focus on the influence of primary surgery...
  13. ncbi Cetuximab monotherapy in advanced cervical cancer: a retrospective study with five patients
    Linda Hertlein
    Department of Obstetrics and Gynecology, Ludwig Maximilians University Munich, Campus Grosshadern, Marchioninistrasse 15, Munich, Germany
    Arch Gynecol Obstet 283:109-13. 2011
    ..In cervical cancer the expression of EGFR is reported in up to 85% of the tumour cells. Therefore, Cetuximab monotherapy could be a new option in the treatment of patients with advanced cervical cancer...
  14. ncbi Thyroid function in breast cancer patients
    Nina Ditsch
    Department of Obstetrics and Gynecology Grosshadern, Ludwig Maximilians University, Munich, Germany
    Anticancer Res 30:1713-7. 2010
    ..In addition, oestrogen-like effects of thyroid hormones on breast cancer cell growth are seen in vitro. Therefore, this study evaluated thyroid function in breast cancer patients, women with benign breast tumour and healthy controls...
  15. ncbi Nelfinavir induces the unfolded protein response in ovarian cancer cells, resulting in ER vacuolization, cell cycle retardation and apoptosis
    Ansgar Brüning
    University Hospital Munich, Department of Obstetrics Gynecology, Maistrasse 11, München 80337, Germany
    Cancer Biol Ther 8:226-32. 2009
    ..Because nelfinavir represents an already approved drug for use in humans with HIV infection, it could rapidly be tested in clinical studies as a potential treatment strategy against drug-resistant ovarian cancer...
  16. ncbi Nelfinavir induces TRAIL receptor upregulation in ovarian cancer cells
    Ansgar Brüning
    University Hospital Munich, Department of Obstetrics Gynecology, Maistrasse 11, 80337 Munich, Germany
    Biochem Biophys Res Commun 377:1309-14. 2008
    ....
  17. ncbi Material differentiation by dual energy CT: initial experience
    Thorsten R C Johnson
    Department of Clinical Radiology, University of Munich Grosshadern Campus, Marchioninistrasse 15, 81377 Munich, Germany
    Eur Radiol 17:1510-7. 2007
    ..Dual energy CT offers a more specific tissue characterization in CT and can improve the assessment of vascular disease. Further studies are required to draw conclusions on the diagnostic value of the individual applications...
  18. ncbi Images in cardiovascular medicine. Detection of cardiac metastasis by positron-emission tomography-computed tomography
    Thorsten R C Johnson
    Department of Clinical Radiology, University of Munich, Munich, Germany
    Circulation 112:e61-2. 2005